The Anson Group is pleased to announce that Dr. Michael Langley is joining the company as a regulatory consultant after retiring from Eli Lilly & Co. Dr. Langley served many roles during his career with Lilly in both animal science and human pharmaceutical products, including director of regulatory affairs and clinical research. Dr. Langley led a number of successful regulatory engagements including both European and US regulatory submissions.
Getting Off Anti-Depressants is Possible, Not Easy
There has been so much press lately about the most popular anti-depressants being over-prescribed I found myself in the thick of this debate because two months ago I decided to begin tapering off my anti-depressant - an SSRI or serotonin reuptake inhibitor
Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. E
Florida based law firm of Freedland Russo publicly revealed the law firm that initiated the nation's largest federal whistleblower case to date, which was unsealed in Philadelphia on Thursday, January 15. As part of a settlement with the U.S. Attorney's Office, Eli Lilly & Company will pay out $1.4 billion in civil and criminal fines related to its illegal and fraudulent marketing of the highly profitable prescription drug Zyprexa.
The Largest Pharma Fraud Whistleblower Case in U.S. History Totals $1.4 Billion
Philadelphia Attorney Stephen Sheller's Whistleblower Clients Help Government Recover $1.4 Billion Record Settlement and Criminal Fine in Eli Lilly & Company Zyprexa(R) Marketing Case. Lead Attorney Filed Complaint in 2003 Representing Six Whistleblowers
Guide to Zoloft
Zoloft is one of the many popular drugs in the SSRI family SSRIýs or selective serotonin reuptake inhibitors are most often prescribed to treat depression, anxiety, post traumatic stress disorder or PTSD and premenstrual dysphoric disorder or PMDD
